<SEC-DOCUMENT>0001104659-25-099728.txt : 20251015
<SEC-HEADER>0001104659-25-099728.hdr.sgml : 20251015
<ACCEPTANCE-DATETIME>20251015160702
ACCESSION NUMBER:		0001104659-25-099728
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251015
DATE AS OF CHANGE:		20251015

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ArriVent BioPharma, Inc.
		CENTRAL INDEX KEY:			0001868279
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94331
		FILM NUMBER:		251394897

	BUSINESS ADDRESS:	
		STREET 1:		18 CAMPUS BLVD.
		STREET 2:		SUITE 100
		CITY:			NEWTOWN SQUARE
		STATE:			PA
		ZIP:			19073-3269
		BUSINESS PHONE:		240-780-6356

	MAIL ADDRESS:	
		STREET 1:		18 CAMPUS BLVD.
		STREET 2:		SUITE 100
		CITY:			NEWTOWN SQUARE
		STATE:			PA
		ZIP:			19073-3269

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ArriVent Biopharma, Inc.
		DATE OF NAME CHANGE:	20210617

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HBM Healthcare Investments (Cayman) Ltd.
		CENTRAL INDEX KEY:			0001232258
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		GOVERNORS SQUARE, 23 LIME TREE BAY AVE.,
		STREET 2:		PO BOX 30852
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1204
		BUSINESS PHONE:		345-946-8002

	MAIL ADDRESS:	
		STREET 1:		GOVERNORS SQUARE, 23 LIME TREE BAY AVE.,
		STREET 2:		PO BOX 30852
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1204

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HBM BIOVENTURES CAYMAN LTD
		DATE OF NAME CHANGE:	20030512
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: HBM Healthcare Investments (Cayman) Ltd. -->
          <cik>0001232258</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, par value $0.0001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>10/08/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001868279</issuerCik>
        <issuerName>ArriVent BioPharma, Inc.</issuerName>
        <issuerCusip>04272N102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>18 Campus Boulevard</com:street1>
          <com:street2>Suite 100</com:street2>
          <com:city>Newtown Square</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19073</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>HBM Healthcare Investments (Cayman) Ltd.</reportingPersonName>
      <citizenshipOrOrganization>E9</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2195014.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2195014.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2195014.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.4</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>Voting and investment power over the shares held by HBM Healthcare Investments (Cayman) Ltd. is exercised by the board of directors of HBM Healthcare Investments (Cayman) Ltd. (the "Board").  The Board consists of Jean-Marc LeSieur, Richard H. Coles, Sophia Harris, Dr. Andreas Wicki, Mark Kronenfeld, M.D., and Richard Paul Woodhouse, none of whom has individual voting or investment power with respect to the shares.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>ArriVent BioPharma, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>18 Campus Boulevard Suite 100 Newtown Square, PA, 19073</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>HBM Healthcare Investments (Cayman) Ltd. (the "Reporting Person")</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Governors Square, 23 Lime Tree Bay Avenue, PO Box 30852, Grand Cayman, KY1-1204, Cayman Islands</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Cayman Islands, British West Indies</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>As of the date hereof, the Reporting Person may be deemed the beneficial owner of 2,195,014 shares of Common Stock, which represent approximately 5.4% of the shares of Common Stock outstanding. The percentage set forth herein is calculated based on 40,568,944 shares of Common Stock outstanding as of August 8, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 11, 2025.</amountBeneficiallyOwned>
        <classPercent>5.4%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>2,195,014</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>2,195,014</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>HBM Healthcare Investments (Cayman) Ltd.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Jean-Marc LeSieur</signature>
        <title>Jean-Marc LeSieur, Managing Director</title>
        <date>10/15/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
